A. C. Chany, C. Tresse, V. Casarotto, and N. Blanchard, History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease), Natural Product Reports, vol.108, issue.12, pp.1527-1567, 2013.
DOI : 10.1039/c3np70068b

C. Demangel, T. P. Stinear, and S. T. Cole, Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009.
DOI : 10.1093/molbev/msm092

K. M. George, D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman et al., Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence, Science, vol.283, issue.5403, pp.854-857, 1999.
DOI : 10.1126/science.283.5403.854

L. Guenin-mace, R. Oldenburg, F. Chretien, and C. , Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens, Cellular and Molecular Life Sciences, vol.198, issue.13, pp.2443-50, 2014.
DOI : 10.1007/s00018-014-1561-z
URL : https://hal.archives-ouvertes.fr/pasteur-01387237

C. Carlier, Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation, J Clin Invest, vol.123, pp.1501-1513, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-00874628

P. Marsollier and . Brodin, Mycobacterial toxin induces analgesia in buruli ulcer by targeting the Angiotensin pathways, Cell, vol.157, pp.1565-1576, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01117565

. Ashford, Histopathologic features of Mycobacterium ulcerans infection, Emerg Infect Dis, vol.9, pp.651-656, 2003.

C. A. Pluschke and . Daubenberger, Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, J Leukoc Biol, vol.79, pp.1150-1156, 2006.

R. Phillips, F. S. Sarfo, L. Guenin-mace, J. Decalf, M. Wansbrough-jones et al., Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease, The Journal of Infectious Diseases, vol.200, issue.11, pp.1675-84, 2009.
DOI : 10.1086/646615
URL : https://hal.archives-ouvertes.fr/pasteur-01402286

R. O. Phillips, F. S. Sarfo, J. Landier, R. Oldenburg, M. Frimpong et al., Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease, PLoS Neglected Tropical Diseases, vol.25, issue.4, p.2786, 2014.
DOI : 10.1371/journal.pntd.0002786.s001
URL : https://hal.archives-ouvertes.fr/pasteur-01384561

H. Hong, E. Coutanceau, M. Leclerc, L. Caleechurn, P. F. Leadlay et al., Mycolactone Diffuses from Mycobacterium ulcerans???Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs, PLoS Neglected Tropical Diseases, vol.23, issue.10, p.325, 2008.
DOI : 10.1371/journal.pntd.0000325.g006

E. Coutanceau, J. Decalf, A. Martino, A. Babon, N. Winter et al., toxin mycolactone, The Journal of Experimental Medicine, vol.22, issue.6, pp.1395-1403, 2007.
DOI : 10.1016/0022-1759(94)90236-4
URL : https://hal.archives-ouvertes.fr/pasteur-01402321

S. Boulkroun, L. Guenin-mace, M. I. Thoulouze, M. Monot, A. Merckx et al., Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events, The Journal of Immunology, vol.184, issue.3, pp.1436-1444, 2010.
DOI : 10.4049/jimmunol.0902854
URL : https://hal.archives-ouvertes.fr/pasteur-00594632

L. Small and C. , Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cell Microbiol, vol.7, pp.1187-1196, 2005.

A. A. Pahlevan, D. J. Wright, C. Andrews, K. M. George, P. L. Small et al., The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function, J Immunol, vol.163, pp.3928-3935, 1999.

R. E. Simmonds, F. V. Lali, T. Smallie, P. L. Small, and B. M. , Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism, The Journal of Immunology, vol.182, issue.4, pp.2194-2202, 2009.
DOI : 10.4049/jimmunol.0802294

B. S. Hall, K. Hill, M. Mckenna, J. Ogbechi, S. High et al., The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER, PLoS Pathogens, vol.103, issue.4, p.1004061, 2014.
DOI : 10.1371/journal.ppat.1004061.s004

L. Guenin-mace, F. Carrette, F. Asperti-boursin, A. Le-bon, L. Caleechurn et al., Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression, Proceedings of the National Academy of Sciences, vol.108, issue.31, pp.12833-12838, 2011.
DOI : 10.1073/pnas.1016496108
URL : https://hal.archives-ouvertes.fr/pasteur-00738806

. Demangel, Mycolactone diffuses into the peripheral blood of buruli ulcer patients implications for diagnosis and disease monitoring, PLoS Negl Trop Dis, vol.5, p.1237, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00691438

J. Mirguet, N. Eustache, and . Blanchard, A diverted total synthesis of mycolactone analogues: an insight into buruli ulcer toxins, Chemistry, vol.17, pp.14413-14419, 2011.

P. Gersbach, A. Jantsch, F. Feyen, N. Scherr, J. P. Dangy et al., A Ring-Closing Metathesis (RCM)-Based Approach to Mycolactones???A/B, Chemistry - A European Journal, vol.7, issue.46, pp.13017-13031, 2011.
DOI : 10.1002/chem.201101799

Y. Kishi, Organic Synthesis Toward Small-Molecule Probes and Drugs Special Feature: Chemistry of mycolactones, the causative toxins of Buruli ulcer, Proc Natl Acad Sci U S A, vol.108, pp.6699-702, 2011.

C. Guenin-mace, N. Demangel, and . Blanchard, Synthetic Variants of Mycolactone Bind and Activate Wiskott-Aldrich Syndrome Proteins, J Med Chem, vol.57, pp.7382-95, 2014.

N. Scherr, P. Gersbach, J. P. Dangy, C. Bomio, J. Li et al., Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans, PLoS Neglected Tropical Diseases, vol.182, issue.3, p.2143, 2013.
DOI : 10.1371/journal.pntd.0002143.s001

W. M. Nauseef and N. Borregaard, Neutrophils at work, Nature Immunology, vol.163, issue.7, pp.602-611, 2014.
DOI : 10.1182/blood-2012-05-431114

J. F. Bisson, S. Hidalgo-lucas, M. Bouschbacher, and L. Thomassin, Effects of TLC-Ag dressings on skin inflammation, The Journal of Dermatology, vol.12, issue.6, pp.463-470, 2013.
DOI : 10.1111/1346-8138.12149

P. A. Alessio, M. Mirshahi, J. F. Bisson, and M. C. Bene, Skin Repair Properties of d-Limonene and Perillyl Alcohol in Murine Models, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, vol.13, issue.1, pp.29-35, 2014.
DOI : 10.2174/18715230113126660021

S. Hunskaar and K. Hole, The formalin test in mice: dissociation between inflammatory and non-inflammatory pain, Pain, vol.30, issue.1, pp.103-114, 1987.
DOI : 10.1016/0304-3959(87)90088-1

L. Guenin-mace, R. Simeone, and C. , Lipids of Pathogenic Mycobacteria: Contributions to Virulence and Host Immune Suppression, Transboundary and Emerging Diseases, vol.43, issue.6-7, pp.255-68, 2009.
DOI : 10.1111/j.1865-1682.2009.01072.x

S. T. Leadlay and . Cole, Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans, Proc Natl Acad Sci U S A, vol.101, pp.1345-1349, 2004.

A. Jenkin, P. L. Small, L. M. Jones, F. Tekaia, F. Laval et al., Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer, Genome Res, vol.17, pp.192-200, 2007.

B. Hall and R. Simmonds, virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer, Biochemical Society Transactions, vol.11, issue.1, pp.177-183, 2014.
DOI : 10.1002/cbic.200400339

A. H. Danser and P. Anand, The Angiotensin II Type 2 Receptor for Pain Control, Cell, vol.157, issue.7, pp.1504-1506, 2014.
DOI : 10.1016/j.cell.2014.05.030

T. Spangenberg and Y. Kishi, Highly sensitive, operationally simple, cost/time effective detection of the mycolactones from the human pathogen Mycobacterium ulcerans, Chemical Communications, vol.66, issue.9, pp.1410-1412, 2010.
DOI : 10.1039/b924896j

H. Oh, B. Siano, and S. Diamond, Neutrophil Isolation Protocol, Journal of Visualized Experiments, vol.17, issue.17, 2008.
DOI : 10.3791/745

D. Dubuisson and S. G. Dennis, The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats, Pain, vol.4, issue.Supp C, pp.161-174, 1977.
DOI : 10.1016/0304-3959(77)90130-0

A. Wisner, E. Dufour, M. Messaoudi, A. Nejdi, A. Marcel et al., Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways, Proceedings of the National Academy of Sciences, vol.103, issue.47, pp.17979-17984, 2006.
DOI : 10.1073/pnas.0605865103